Omnilytics

OmniLytics, Incorporated is a biotech company that is focused on developing safe, natural solutions for infectious disease and pest control. OmniLytics is located in Salt Lake City, Utah with official presence in Honduras, Ecuador, and El Salvador. With emphasis on bacteriophage technology, OmniLytics is pioneering research and development of bacteriophage solutions for pathogen control in the,, and defense markets. OmniLytics' proprietary formulas and processes optimize the use of natural bacteriophage for commercial applications. Bacteriophage solutions are natural, environmentally friendly, safe and effective. OmniLytics is primarily a research and development entity and derives its revenue from the sale of its products directly into certain markets or licensing agreements with its business units ( subsidiaries ) and strategic partners. OmniLytics' historical background dates back to 1954 and includes expansive research, development, knowledge, and expertise using natural products to control dangerous pathogens in a variety of market segments ; although the majority of the work over the last ten years has focused on agricultural diseases. As a result of this work, the company has developed several economical and effective products to control destructive plant and animal bacterial diseases that have become resistant to traditional antimicrobial agents. OmniLytics' products are made using bacteriophage mixtures. Bacteriophage, or phage , are viruses that attack only bacteria. Phage are very specific and only kill a particular species of bacteria. Unlike antibiotics and other chemicals, they will not kill other good bacteria, beneficial micro flora or fauna, and have no negative impact on other forms of life or the environment. As a result, the company's products provide a clean alternative to synthetically produced chemicals that leave behind toxic residues that can adversely affect human health and the environment.